- Home
- PCVX vs MAIN Comparison
PCVX vs MAIN Comparison
Compare PCVX & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- MAIN
- Stock Information
- Founded
- PCVX 2013
- MAIN 2007
- Country
- PCVX United States
- MAIN United States
- Employees
- PCVX N/A
- MAIN N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- MAIN Finance/Investors Services
- Sector
- PCVX Health Care
- MAIN Finance
- Exchange
- PCVX Nasdaq
- MAIN Nasdaq
- Market Cap
- PCVX 6.0B
- MAIN 5.8B
- IPO Year
- PCVX 2020
- MAIN 2007
- Fundamental
- Price
- PCVX $49.03
- MAIN $58.67
- Analyst Decision
- PCVX Strong Buy
- MAIN Hold
- Analyst Count
- PCVX 7
- MAIN 6
- Target Price
- PCVX $101.67
- MAIN $60.33
- AVG Volume (30 Days)
- PCVX 1.3M
- MAIN 474.4K
- Earning Date
- PCVX 11-04-2025
- MAIN 11-06-2025
- Dividend Yield
- PCVX N/A
- MAIN 7.29%
- EPS Growth
- PCVX N/A
- MAIN 9.36
- EPS
- PCVX N/A
- MAIN 6.03
- Revenue
- PCVX N/A
- MAIN $561,290,000.00
- Revenue This Year
- PCVX N/A
- MAIN $6.11
- Revenue Next Year
- PCVX N/A
- MAIN $3.41
- P/E Ratio
- PCVX N/A
- MAIN $9.69
- Revenue Growth
- PCVX N/A
- MAIN 5.92
- 52 Week Low
- PCVX $27.66
- MAIN $47.00
- 52 Week High
- PCVX $98.17
- MAIN $67.77
- Technical
- Relative Strength Index (RSI)
- PCVX 69.14
- MAIN 48.24
- Support Level
- PCVX $40.14
- MAIN $56.31
- Resistance Level
- PCVX $45.90
- MAIN $59.58
- Average True Range (ATR)
- PCVX 2.30
- MAIN 1.23
- MACD
- PCVX 0.26
- MAIN 0.38
- Stochastic Oscillator
- PCVX 91.15
- MAIN 72.90
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About MAIN Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.